Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 08 November, 2018

GlaxoSmithKline PLC

Director Declaration

RNS Number : 8075G
GlaxoSmithKline PLC
08 November 2018
 

 

 

GlaxoSmithKline plc

 

Director Declaration

 

In conformity with Listing Rule 9.6.14, GlaxoSmithKline plc (the 'Company') hereby notifies the market that Dr Jesse Goodman, a Non-Executive Director of the Company, has been appointed as a Director to the Board of Intellia Therapeutics, Inc. with effect from 31 October 2018.

 

 

V A Whyte

Company Secretary

 

8 November 2018

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNEAAFPELAPFFF

a d v e r t i s e m e n t